현기증 치료 시장 : 유형별, 치료법별, 투여 경로별, 최종 사용자별, 지역별

The global vertigo treatments market is estimated to be valued at USD 1.53 Bn in 2024 and is expected to reach USD 2.24 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.

Figure. Vertigo Treatments Market Share (%), By Region 2024

Vertigo refers to a condition where a person feels as if they or everything around them is moving or spinning, even though they are stationary. It is typically caused due to imbalance in the inner ear. Aging population has contributed greatly to the rising prevalence of vertigo across major markets. According to the National Library of Medicine estimates in June 2023, over 12% of adults aged 60 years and above experience vertigo at least once in their lifetime. Various treatment options are available for vertigo including medications, vestibular rehabilitation therapy, balance retraining programs, surgical treatments, etc. Advancements in diagnosis and introduction of novel therapeutics are supporting the market expansion.

Market Dynamics:

Rising geriatric populace, growing cases of neurological disorders causing vertigo, and new product approvals and launches are some of the key factors driving the global vertigo treatments market. However, risks associated with surgical treatments, social stigma around vertigo and high costs of branded therapies are certain challenges restraining the market growth. On the opportunities side, untreated vertigo imposes a huge economic burden globally. Growing medical tourism in developing nations and technological developments in vertigo management devices present valuable prospects for market players. Collaborations between medical device innovators and healthcare providers can help address unmet needs more effectively.

Key Features of the Study:

This report provides in-depth analysis of the global vertigo treatments market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vertigo treatments market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic Abbott Laboratories, Siemens Healthineers, Johnson & Johnson, Oticon, Cochlear Limited, Auris Medical Holding AG, Otonomy, Inc., Sensorion SA, Sound Pharmaceuticals Inc., GSK (GlaxoSmithKline), Merck & Co., Pfizer Inc., Novartis AG, and Bayer AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vertigo treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vertigo treatments market

Market Segmentation

• By Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Central Vertigo
  • Peripheral Vertigo
• By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
  • Medication
  • Anticholinergics
  • Antihistamines
  • Benzodiazepines
  • Others
  • Surgery/Therapy
• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Oral
  • Topical
  • Parenteral
  • Others
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Clinics
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Medtronic
  • Abbott Laboratories
  • Siemens Healthineers
  • Johnson & Johnson
  • Oticon
  • Cochlear Limited
  • Auris Medical Holding AG
  • Otonomy, Inc.
  • Sensorion SA
  • Sound Pharmaceuticals, Inc.
  • GSK (GlaxoSmithKline)
  • Merck & Co.
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Vertigo Treatments Market, By Type
  • Global Vertigo Treatments Market, By Treatment
  • Global Vertigo Treatments Market, By Route of Administration
  • Global Vertigo Treatments Market, By End User
  • Global Vertigo Treatments Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Vertigo Treatments Market, By Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Central Vertigo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Peripheral Vertigo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vertigo Treatments Market, By Treatment, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Anticholinergics
• Antihistamines
• Benzodiazepines
• Others
• Surgery/Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vertigo Treatments Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vertigo Treatments Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Vertigo Treatments Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oticon
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cochlear Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Auris Medical Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Otonomy, Inc.
• Sensorion SA
• Sound Pharmaceuticals, Inc.
• GSK (GlaxoSmithKline)
• Merck & Co.
• Pfizer Inc.
• Novartis AG
• Bayer AG

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us